Home > Raptor Pharmaceuticals Salary

Raptor Pharmaceuticals Salary

  • 11
  • 12
  • 61
Raptor Pharmaceuticals average salary is $91,686, median salary is $91,686 with a salary range from $91,686 to $91,686.
Raptor Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Raptor Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
91,686
Average
91,686
Median
91,686
High
91,686
Total 1 Raptor Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Computer System Administrator 91,686-91,686 Chicago, IL, 60601 2015 Raptor Pharmaceuticals Computer System Administrator Salaries (2)
Raptor Pharmaceuticals Chicago, IL Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Raptor Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Raptor Pharmaceuticals Jobs
See more Raptor Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Raptor Pharmaceuticals... Information
  • Raptor Pharmaceuticals Corp
  • Industry: BioTech/Drugs
  • City: Novato, CA
  • Raptor Pharmaceuticals Corp. (Raptor Corp.) seeks to acquire, develop and commercialize a portfolio of pharmaceutical products for a range of therapeutic indications. Raptor Corp.¡¯s strategy includes acquiring or in-licensing and developing novel product candidates that target large pharmaceutical markets, which can be rapidly commercialized. Typically, these markets and compounds have been overlooked by major pharmaceutical companies. Raptor Corp. is also developing product candidates to treat orphan indications which, due to their smaller patient population, could potentially have a shorter regulatory pathway. Raptor Corp.¡¯s experienced management team oversees the human clinical trials necessary to establish preliminary evidence